7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

DiaMedica Therapeutics Inc
(NASDAQ:DMAC) 

DMAC stock logo

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. Its lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which has completed Phase Ib clinical trials for the treatment of patients with modera...

Founded: 2000
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
Pharmaceuticals
Share this website to your friends
DiaMedica Therapeutics Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 07.7315.4523.1830.938.6346.3654.08
DiaMedica Therapeutics Days Receivable Outstanding ttm (DSO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0128.98257.97386.95515.94644.92773.91902.89
DiaMedica Therapeutics Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -5.12-4.39-3.66-2.93-2.2-1.46-0.730
DiaMedica Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.56-0.48-0.4-0.32-0.24-0.16-0.080
DiaMedica Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.56-0.48-0.4-0.32-0.24-0.16-0.080
DiaMedica Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.210.420.630.841.061.271.48
DiaMedica Therapeutics P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0263.12526.24789.361,052.471,315.591,578.711,841.83
DiaMedica Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -7.4-6.34-5.29-4.23-3.17-2.11-1.060
DiaMedica Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.61.211.812.423.023.624.23
No extra charts and metrics for this ticker.